Aerosol characterization of alpha-1 antitrypsin after nebulization with eFlow®, a novel vibrating membrane nebulizer

M. Tservistas, E. Bitterle, M. Keller, S. Bauer (Munich, Germany; Rehovot, Israel)

Source: Annual Congress 2006 - Update on treatment of COPD II
Session: Update on treatment of COPD II
Session type: Thematic Poster Session
Number: 2515
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Tservistas, E. Bitterle, M. Keller, S. Bauer (Munich, Germany; Rehovot, Israel). Aerosol characterization of alpha-1 antitrypsin after nebulization with eFlow®, a novel vibrating membrane nebulizer. Eur Respir J 2006; 28: Suppl. 50, 2515

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Aerosol characteristics of a unique breath-actuated nebulizer
Source: International Congress 2017 – Lung function practice in daily life
Year: 2017


Particle size and gravimetric characteristics of Clenny Aerosol, a new jet nebulizer with breath enhanced bulb
Source: Eur Respir J 2001; 18: Suppl. 33, 99s
Year: 2001

Aerosol performance of two ambroxol inhalation products upon nebulisation by the eFlow rapid
Source: Eur Respir J 2006; 28: Suppl. 50, 212s
Year: 2006

Improvement of pulmonary drug delivery by eFlow™, a novel electronic inhaler making use of a vibrating membrane principle
Source: Eur Respir J 2003; 22: Suppl. 45, 472s
Year: 2003

Assessment on the efficiency of Clenny Aerosol, a new jet nebulizer with breath-enhanced bulb
Source: Eur Respir J 2001; 18: Suppl. 33, 101s
Year: 2001

Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008


Aerosol characterization of three corticosteroids in MDIs plus a new spacer device (Fluspacer®) vs MDIs alone
Source: Eur Respir J 2001; 18: Suppl. 33, 101s
Year: 2001

Aerosol delivery characteristics from a new jet nebulizer in comparison with commercially available jet nebulizers
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008

Effect of device and formulation on delivery of budesonide suspensions by nebulizers
Source: Eur Respir J 2002; 20: Suppl. 38, 542s
Year: 2002

Successful conversion of patients using nebulised iloprost from multisonic nebuliser to adaptive aerosol delivery nebuliser
Source: Eur Respir J 2007; 30: Suppl. 51, 345s
Year: 2007

The generation of monodisperse pharmacological aerosols using a spinning-top aerosol generator (STAG)
Source: Eur Respir J 2005; 26: Suppl. 49, 125s
Year: 2005

Delivery of dornase alfa via breath-actuated nebulizer: In-vitro measures of performance
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Reduction of nebulization time can be achieved with a new jet nebulizer design
Source: Eur Respir J 2006; 28: Suppl. 50, 211s
Year: 2006

In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation.
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



Functional testing of the Omron MicroAir, a vibrating mesh nebulizer
Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Year: 2007


Relative lung deposition of tobramycin from a MicroAir nebuliser
Source: Eur Respir J 2006; 28: Suppl. 50, 667s
Year: 2006

In-vitro nebulised dose emission characteristics of a tobramycin solution (75mg/ml) using an I-Neb (I-NEB) and a pari LC+ driven by a TurboBoy compressor (PARI) nebuliser
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011


In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer.
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019